Press "Enter" to skip to content

International AIDS Conference 2020: The Way the coronavirus Catastrophe is hitting the Struggle against HIV/AIDS

The most crucial worldwide gathering of the brightest minds combating AIDS — scientists, physicians, activists, and people living with the disorder — has been held online this season, at the shadow of this coronavirus pandemic.

A few 25,000 participants are expected to log on this week to the 23rd global AIDS Conference, which can also research the way the COVID-19 catastrophe is impacting medical services for HIV patients.

The Joint United Nations Programme on HIV/AIDS (UNAIDS) has estimated that in an “intense” situation, COVID-19 disruptions in HIV therapy could bring about an extra 500,000 deaths in sub-Saharan Africa, where greater two-thirds of people with HIV live.

Medical and fiscal resources are redirected towards the battle against COVID-19, which makes it more challenging to handle the continuing HIV outbreak, says Dr. Anton Pozniak, president of this International AIDS Society (IAS).

“Nurses, physicians have had to be managing the coronavirus outbreak. Studies have been placed on a freeze,” Pozniak informed Euronews.

“Lots of individuals with HIV have self-isolated, been careful about what they are being subjected to,” he added.

But, there are ways to mitigate the effect of the pandemic on HIV patients,” he explained.

“What we have done in many nations is ensure that they don’t have to come to practices as often. A lot of these were coming each month,” Pozniak clarified.

“We state come every 3 months; we have made sure they have had enough tablets to take while they have been at home. And we have been providing them support in which it is potential by telemedicine, phone and text messaging”

UNAIDS has insisted that there’s still time to make sure people receive the HIV treatment solutions they want and that condoms remain readily accessible to reduce transmission.

Worldwide, almost 38 million individuals reside with HIV/AIDS. In the last few decades, scientists have made strides in creating treatments and vaccines. However, despite treating another individual of this disorder in 2019, analysts state there is a very long way to go.